New hope for endometriosis: Anti-Inflammatory drug before embryo transfer may boost pregnancy success
NCT ID NCT07509411
First seen Apr 07, 2026 · Last updated May 01, 2026 · Updated 2 times
Summary
This study tests whether giving an anti-TNFα drug (a type of anti-inflammatory) a few days before transferring a frozen embryo can improve pregnancy rates in women with endometriosis who have already had a failed IVF cycle. The trial involves 145 women and focuses on whether the treatment helps the womb lining accept the embryo. The goal is to see if calming inflammation can lead to more successful pregnancies and healthier babies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benha university
Banhā, El Qalyoubia, 13511, Egypt
Conditions
Explore the condition pages connected to this study.